Kwaku Ohene-Frempong, MD Named a 2021 Honorific Award Recipient by the American Society of Hematology
Published on
Kwaku Ohene-Frempong, MD was named a 2021 Honorific Award Recipient by the American Society of Hematology.
Published on
Kwaku Ohene-Frempong, MD was named a 2021 Honorific Award Recipient by the American Society of Hematology.
Published on
CHOP researchers have developed a proof-of-concept treatment for blood disorders like sickle cell disease that elevates both fetal and adult hemoglobin.
Published on
CHOP researchers were interviewed as a part of a comprehensive article about cell and gene therapy in Philadelphia Magazine.
Published on
CHOP researchers have identified BAFF as a key target that may be responsible for treatment failure in about 30% of patients with hemophilia A.
Published on
The findings identify possible targets for future therapies for ribosomopathies, childhood disorders that lead to bone marrow failure (BMF).
Published on
CHOP researchers have developed a gene therapy vector for sickle cell disease and other blood disorder that is potentially superior to competitors.
Published on
CHOP researchers identified an in vivo role for activated protein C (APC), which could potentially be exploited for future hemophilia A treatments.
Published on
CHOP researchers found the elevated biomarker in all children who tested positive for SARS-CoV-2, whether they were symptomatic for COVID-19 or not.
Published on
Fears of catching Covid-19 in ERs forced many in the throes of pain crises to avoid seeking medical attention. Dr. Kim Smith-Whitley explains the importance of seeking care in a COVID-19 world.
Published on
Millions of Americans carry the sickle cell trait, many without knowing it. Could they be at risk for severe Covid-19? Stat News Reports.